{"id":"https://openalex.org/W1968656157","doi":"https://doi.org/10.1371/journal.pone.0020775","title":"Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-\u03b1 Producing Effector and Central Memory CD4+ T Cells","display_name":"Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-\u03b1 Producing Effector and Central Memory CD4+ T Cells","alternate_titles":[],"publication_year":2011,"publication_date":"2011-07-11","ids":{"openalex":"https://openalex.org/W1968656157","doi":"https://doi.org/10.1371/journal.pone.0020775","mag":"1968656157","pmid":"https://pubmed.ncbi.nlm.nih.gov/21779319","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3136919"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0020775","doi":"https://doi.org/10.1371/journal.pone.0020775","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0020775","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020775&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968656157"],"child_works_count":8,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020775&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072436976","display_name":"Joanne M. Lumsden","orcid":"https://orcid.org/0000-0002-0730-9946","observed_orcids":["https://orcid.org/0000-0002-0730-9946"]},"institutions":[{"id":"https://openalex.org/I92664306","display_name":"Walter Reed Army Institute of Research","ror":"https://ror.org/0145znz58","country_code":"US","type":"government","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2802581893","https://openalex.org/I92664306"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joanne M. Lumsden","raw_affiliation_strings":["Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America","institution_ids":["https://openalex.org/I92664306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110015843","display_name":"Robert Schwenk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92664306","display_name":"Walter Reed Army Institute of Research","ror":"https://ror.org/0145znz58","country_code":"US","type":"government","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2802581893","https://openalex.org/I92664306"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert J. Schwenk","raw_affiliation_strings":["Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America","institution_ids":["https://openalex.org/I92664306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102979107","display_name":"Lisa Rein","orcid":"https://orcid.org/0000-0003-3867-2577","observed_orcids":["https://orcid.org/0000-0003-3867-2577"]},"institutions":[{"id":"https://openalex.org/I92664306","display_name":"Walter Reed Army Institute of Research","ror":"https://ror.org/0145znz58","country_code":"US","type":"government","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2802581893","https://openalex.org/I92664306"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa E. Rein","raw_affiliation_strings":["Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America","institution_ids":["https://openalex.org/I92664306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109008301","display_name":"Philippe Moris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philippe Moris","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium","GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]},{"raw_affiliation_string":"GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040449126","display_name":"Michel Janssens","orcid":"https://orcid.org/0000-0002-8800-9071","observed_orcids":["https://orcid.org/0000-0002-8800-9071"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michel Janssens","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium","GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]},{"raw_affiliation_string":"GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083056084","display_name":"Opokua Ofori\u2010Anyinam","orcid":"https://orcid.org/0000-0001-8099-6837","observed_orcids":["https://orcid.org/0000-0001-8099-6837"]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Opokua Ofori-Anyinam","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium","GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]},{"raw_affiliation_string":"GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015438763","display_name":"Joe Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joe Cohen","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Rixensart, Belgium","GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]},{"raw_affiliation_string":"GlaxoSmithKline#N#          Biologicals, Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080329476","display_name":"Kent E. Kester","orcid":"https://orcid.org/0000-0002-5056-0802","observed_orcids":["https://orcid.org/0000-0002-5056-0802"]},"institutions":[{"id":"https://openalex.org/I92664306","display_name":"Walter Reed Army Institute of Research","ror":"https://ror.org/0145znz58","country_code":"US","type":"government","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2802581893","https://openalex.org/I92664306"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kent E. Kester","raw_affiliation_strings":["Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America","institution_ids":["https://openalex.org/I92664306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111689459","display_name":"D. Gray Heppner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92664306","display_name":"Walter Reed Army Institute of Research","ror":"https://ror.org/0145znz58","country_code":"US","type":"government","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2802581893","https://openalex.org/I92664306"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Gray Heppner","raw_affiliation_strings":["Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America","institution_ids":["https://openalex.org/I92664306"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113164625","display_name":"Urszula Krzych","orcid":"https://orcid.org/0009-0008-2900-1150","observed_orcids":["https://orcid.org/0009-0008-2900-1150"]},"institutions":[{"id":"https://openalex.org/I92664306","display_name":"Walter Reed Army Institute of Research","ror":"https://ror.org/0145znz58","country_code":"US","type":"government","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2802581893","https://openalex.org/I92664306"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Urszula Krzych","raw_affiliation_strings":["Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America","institution_ids":["https://openalex.org/I92664306"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113164625"],"corresponding_institution_ids":["https://openalex.org/I92664306"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":7.6427,"has_fulltext":true,"cited_by_count":98,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97482999,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"6","issue":"7","first_page":"e20775","last_page":"e20775"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.016899999231100082,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasmodium-falciparum-circumsporozoite-protein","display_name":"Plasmodium falciparum circumsporozoite protein","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9110000133514404},{"id":"https://openalex.org/keywords/effector-memory-t-cells","display_name":"effector memory T cells","score":0.8989999890327454},{"id":"https://openalex.org/keywords/central-memory-t-cells","display_name":"central memory T cells","score":1.0},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.984000027179718},{"id":"https://openalex.org/keywords/vaccine-induced-immunity","display_name":"vaccine-induced immunity","score":0.6740000247955322},{"id":"https://openalex.org/keywords/sterile-immunity","display_name":"sterile immunity","score":0.656000018119812},{"id":"https://openalex.org/keywords/correlates-of-protection","display_name":"correlates of protection","score":0.6690000295639038},{"id":"https://openalex.org/keywords/sporozoite-challenge","display_name":"sporozoite challenge","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.5798565149307251},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5775537490844727},{"id":"https://openalex.org/C2781074509","wikidata":"https://www.wikidata.org/wiki/Q24778282","display_name":"Circumsporozoite protein","level":4,"score":0.5736599564552307},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.5718396902084351},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5665261149406433},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.5650784373283386},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5432911515235901},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.5161812901496887},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4900456666946411},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4779910445213318},{"id":"https://openalex.org/C2776789287","wikidata":"https://www.wikidata.org/wiki/Q7166532","display_name":"Peptide vaccine","level":4,"score":0.4770773649215698},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46462947130203247},{"id":"https://openalex.org/C3017875465","wikidata":"https://www.wikidata.org/wiki/Q189146","display_name":"Cellular immunity","level":3,"score":0.4519363343715668},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4505329132080078},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.19325131177902222}],"mesh":[{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017780","descriptor_name":"Malaria Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017780","descriptor_name":"Malaria Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1371/journal.pone.0020775","doi":"https://doi.org/10.1371/journal.pone.0020775","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0020775","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020775&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3136919","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3136919/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:21779319","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21779319","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:doaj.org/article:15d32dd5c3414b5f9155b9d7893030d0","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/15d32dd5c3414b5f9155b9d7893030d0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 6, Iss 7, p e20775 (2011)","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.350.1254","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.350.1254","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/1a/97/PLoS_One_2011_Jul_11_6(7)_e20775.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0020775","doi":"https://doi.org/10.1371/journal.pone.0020775","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0020775","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020775&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320310334","display_name":"RTI International","ror":"https://ror.org/052tfza37"},{"id":"https://openalex.org/F4320332447","display_name":"U.S. Army","ror":"https://ror.org/00afsp483"},{"id":"https://openalex.org/F4320338325","display_name":"Walter Reed Army Institute of Research","ror":"https://ror.org/0145znz58"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1968656157.pdf","grobid_xml":"https://content.openalex.org/works/W1968656157.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1577972394","https://openalex.org/W1580057258","https://openalex.org/W1670334165","https://openalex.org/W1851307961","https://openalex.org/W1964629907","https://openalex.org/W1965145857","https://openalex.org/W1971719400","https://openalex.org/W1974433492","https://openalex.org/W1974707250","https://openalex.org/W1981480494","https://openalex.org/W2022863293","https://openalex.org/W2033970156","https://openalex.org/W2038621149","https://openalex.org/W2038910210","https://openalex.org/W2044186768","https://openalex.org/W2057099099","https://openalex.org/W2063122125","https://openalex.org/W2066738380","https://openalex.org/W2076510057","https://openalex.org/W2080051685","https://openalex.org/W2098425996","https://openalex.org/W2107181087","https://openalex.org/W2111344966","https://openalex.org/W2127104623","https://openalex.org/W2129044432","https://openalex.org/W2135604731","https://openalex.org/W2157034871","https://openalex.org/W2157427941","https://openalex.org/W2163861382","https://openalex.org/W2165771585","https://openalex.org/W2171564990","https://openalex.org/W2171633892"],"related_works":["https://openalex.org/W1996231427","https://openalex.org/W2157427941","https://openalex.org/W2047316862","https://openalex.org/W2097340000","https://openalex.org/W2151784087","https://openalex.org/W2760237399","https://openalex.org/W2612894522","https://openalex.org/W1973480720","https://openalex.org/W1999838130"],"abstract_inverted_index":{"A":[0],"phase":[1],"2a":[2],"RTS,S/AS":[3,259],"malaria":[4],"vaccine":[5,260],"trial,":[6],"conducted":[7],"previously":[8],"at":[9],"the":[10,30,35,68,96,105,134,137,165,175,186,192],"Walter":[11],"Reed":[12],"Army":[13],"Institute":[14],"of":[15,29,39,65,92,99,140,146,177,188,214,222,273],"Research,":[16],"conferred":[17],"sterile":[18],"immunity":[19,262],"against":[20],"a":[21,171,202,254],"primary":[22,97],"challenge":[23],"with":[24,129],"infectious":[25],"sporozoites":[26],"in":[27,34,51,67,127,191,237,247],"40%":[28],"80":[31],"subjects":[32,53,113,152],"enrolled":[33],"study.":[36],"The":[37,212],"frequency":[38,176],"Plasmodium":[40],"falciparum":[41],"circumsporozoite":[42],"protein":[43],"(CSP)-specific":[44],"CD4(+)":[45,84,142,147,180,218,223],"T":[46,85,181],"cells":[47,86,119,144,149,182,208,220,225,269],"was":[48],"significantly":[49,154],"higher":[50,155,236],"protected":[52,151,238],"as":[54,201],"compared":[55],"to":[56,234,249,258],"non-protected":[57,159,240],"subjects.":[58,160],"Intrigued":[59],"by":[60],"these":[61,93],"unique":[62],"vaccine-related":[63],"correlates":[64],"protection,":[66],"present":[69],"study":[70],"we":[71],"asked":[72],"whether":[73,88],"RTS,S":[74],"also":[75,162,232,253],"induced":[76,261],"effector/effector":[77],"memory":[78,82],"(T(E/EM))":[79],"and/or":[80,209],"central":[81],"(T(CM))":[83],"and":[87,117,136,145,185,221,229,263,267],"one":[89],"or":[90],"both":[91,115,133,227,265],"sub-populations":[94],"is":[95,170,252],"source":[98],"cytokine":[100],"production.":[101],"We":[102,161,242],"showed":[103],"for":[104,164,205],"first":[106,166],"time":[107,167],"that":[108,120,168,196,246,264],"PBMC":[109],"from":[110,150,158],"malaria-non-exposed":[111],"RTS,S-immunized":[112],"contain":[114],"T(E/EM)":[116,143,219,224,266],"T(CM)":[118,148,268],"generate":[121],"strong":[122,172],"IL-2":[123,184,197,228,251],"responses":[124],"following":[125],"re-stimulation":[126],"vitro":[128],"CSP":[130,178,215],"peptides.":[131],"Moreover,":[132],"frequencies":[135,213],"total":[138],"numbers":[139],"IL-2-producing":[141],"were":[153,231],"than":[156],"those":[157],"demonstrated":[163,245],"there":[169],"association":[173],"between":[174],"peptide-reactive":[179],"producing":[183],"titers":[187],"CSP-specific":[189],"antibodies":[190],"same":[193],"individual,":[194],"suggesting":[195],"may":[198],"be":[199,235],"acting":[200],"growth":[203],"factor":[204,257],"follicular":[206],"Th":[207],"B":[210],"cells.":[211],"peptide-reactive,":[216],"TNF-\u03b1-producing":[217],"secreting":[226],"TNF-\u03b1":[230],"shown":[233],"vs.":[239],"individuals.":[241],"have,":[243],"therefore,":[244],"addition":[248],"TNF-\u03b1,":[250],"significant":[255],"contributing":[256],"are":[270],"major":[271],"producers":[272],"IL-2.":[274]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1968656157","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
